CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death.

Chung, Alexander H; Leisner, Tina M; Dardis, Gabrielle J; Bivins, Marissa M; Keller, Alana L; Parise, Leslie V

Chung, Alexander H; Leisner, Tina M; Dardis, Gabrielle J; Bivins, Marissa M; Keller, Alana L; Parise, Leslie V.

Afiliación

Chung AH; 1Department of Pharmacology, University of North Carolina at Chapel Hill, CB #7365, Chapel Hill, NC 27599 USA.
Leisner TM; 2Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, CB #7260, Chapel Hill, NC 27599 USA.
Dardis GJ; 2Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, CB #7260, Chapel Hill, NC 27599 USA.
Bivins MM; 1Department of Pharmacology, University of North Carolina at Chapel Hill, CB #7365, Chapel Hill, NC 27599 USA.
Keller AL; 2Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, CB #7260, Chapel Hill, NC 27599 USA.
Parise LV; 2Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, CB #7260, Chapel Hill, NC 27599 USA.

Cancer Cell Int ; 19: 26, 2019.

Article en En | MEDLINE | ID: mdl-30740034

Palabras clave

Apoptosis; CIB1; Chemoresistance; TRAIL; Triple-negative breast cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google